• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T4 水平测量的胸肌面积与住院患者 COVID-19 不良结局密切相关。

Pectoralis muscle area measured at T4 level is closely associated with adverse COVID-19 outcomes in hospitalized patients.

机构信息

Istanbul Medeniyet University, Goztepe Prof Dr Suleyman Yalcin City Hospital, Radiology, Istanbul, Turkey.

Istanbul Medeniyet University, Goztepe Prof Dr Suleyman Yalcin City Hospital, Physical Medicine and Rehabilitation, Istanbul, Turkey.

出版信息

J Musculoskelet Neuronal Interact. 2023 Jun 1;23(2):196-204.

PMID:37259659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10233225/
Abstract

OBJECTIVES

Skeletal muscle area (SMA) at T4 level on chest computed tomography (CT) is a newly available method that can be used as a surrogate sarcopenia marker. The objective of this study is to evaluate association of SMA with adverse COVID-19 outcomes in hospitalized patients.

METHODS

Hospitalized COVID-19 patients were prospectively recorded in a database containing age, gender, date of admission, date of outcome (discharge, mortality, presence of intensive care unit (ICU) stay, additional coding information (comorbidities, superimposed conditions). Admission CT-scans were retrospectively evaluated for segmentation (bilateral pectoralis major/minor, erector spinae, levator scapulae, rhomboideus minor and major and transversospinalis muscles) and SMA calculation using 3-D slicer software.

RESULTS

167 cases were evaluated (68 male, 72 female, 140 survived, 27 dead). Muscle area was lower in patients with ICU stay (p=0.023, p=0.018, p=0.008) and mortality outcome (p=0.004, p=0.007, p=0.002) for pectoralis, back and SMA. In multivariate Cox-regression analysis, hazard ratio (HR) value for the pectoralis muscle area value below 2800 mm was found to be 3.138(95% CI: 1.171-8.413) for mortality and 2.361(95% CI: 1.012-5.505) for ICU.

CONCLUSIONS

Pectoralis muscle area measured at T4 level with 3-D slicer was closely associated with adverse outcomes (mortality, ICU stay) in hospitalized COVID-19 patients. Since early treatment methods for COVID-19 are being evaluated, this method may be a useful adjunct to clinical decision making in regard to prioritization.

摘要

目的

胸部 CT 第四胸椎水平骨骼肌面积(SMA)是一种新的可用于替代肌少症标志物的方法。本研究的目的是评估 SMA 与住院 COVID-19 患者不良结局的关系。

方法

前瞻性地将住院 COVID-19 患者记录在包含年龄、性别、入院日期、出院日期、死亡日期、是否入住重症监护病房(ICU)、附加编码信息(合并症、叠加疾病)的数据库中。回顾性评估入院 CT 扫描以进行分割(双侧胸大肌/胸小肌、竖脊肌、肩胛提肌、小菱形肌和大菱形肌以及横突间肌),并使用 3-D slicer 软件计算 SMA。

结果

共评估了 167 例病例(68 例男性,72 例女性,140 例存活,27 例死亡)。在 ICU 入住(p=0.023,p=0.018,p=0.008)和死亡结局(p=0.004,p=0.007,p=0.002)的患者中,胸肌和背部以及 SMA 的肌肉面积较低。多变量 Cox 回归分析显示,胸肌面积值低于 2800mm 的患者死亡风险 HR 值为 3.138(95%CI:1.171-8.413),入住 ICU 的 HR 值为 2.361(95%CI:1.012-5.505)。

结论

使用 3-D slicer 在第四胸椎水平测量的胸肌面积与住院 COVID-19 患者的不良结局(死亡、入住 ICU)密切相关。由于正在评估 COVID-19 的早期治疗方法,该方法可能有助于临床决策,以便优先考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5546/10233225/1a77f033d502/JMNI-23-196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5546/10233225/cf0c950b4435/JMNI-23-196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5546/10233225/1a77f033d502/JMNI-23-196-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5546/10233225/cf0c950b4435/JMNI-23-196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5546/10233225/1a77f033d502/JMNI-23-196-g002.jpg

相似文献

1
Pectoralis muscle area measured at T4 level is closely associated with adverse COVID-19 outcomes in hospitalized patients.T4 水平测量的胸肌面积与住院患者 COVID-19 不良结局密切相关。
J Musculoskelet Neuronal Interact. 2023 Jun 1;23(2):196-204.
2
Acute skeletal muscle loss in SARS-CoV-2 infection contributes to poor clinical outcomes in COVID-19 patients.严重急性呼吸综合征冠状病毒 2 感染导致骨骼肌大量丢失,与 COVID-19 患者的临床预后不良有关。
J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2436-2446. doi: 10.1002/jcsm.13052. Epub 2022 Jul 19.
3
Integrated assessment of computed tomography density in pectoralis and erector spinae muscles as a prognostic biomarker for coronavirus disease 2019.胸大肌和竖脊肌 CT 密度的综合评估可作为 2019 冠状病毒病的预后生物标志物。
Clin Nutr. 2024 Mar;43(3):815-824. doi: 10.1016/j.clnu.2024.02.004. Epub 2024 Feb 5.
4
Impact of Pectoral Muscle Values on Clinical Outcomes in Patients With Severe Covid-19 Disease.胸肌值对重症 COVID-19 患者临床结局的影响。
In Vivo. 2022 Jan-Feb;36(1):375-380. doi: 10.21873/invivo.12713.
5
Commentary to: Pectoralis Muscle Area Measured at T4 Level is Closely Associated With Adverse COVID-19 Outcomes in Hospitalized Patients.对《T4水平测量的胸肌面积与住院COVID-19患者不良预后密切相关》的评论
J Musculoskelet Neuronal Interact. 2024 Mar 1;24(1):101.
6
Prognostic Role of the Pectoralis Musculature in Patients with COVID-19. A Multicenter Study.胸肌在 COVID-19 患者中的预后作用。一项多中心研究。
Acad Radiol. 2023 Jan;30(1):77-82. doi: 10.1016/j.acra.2022.05.003. Epub 2022 May 16.
7
Feasibility of assessment of skeletal muscle mass on a single cross-sectional image at the level of the fourth thoracic vertebra.第四胸椎水平单一切面图像评估骨骼肌量的可行性。
Eur J Radiol. 2021 Sep;142:109879. doi: 10.1016/j.ejrad.2021.109879. Epub 2021 Jul 26.
8
CT-defined pectoralis muscle mass and muscle density are associated with mortality in acute pulmonary embolism. A multicenter analysis.CT 定义的胸肌质量和肌肉密度与急性肺栓塞的死亡率相关。一项多中心分析。
Clin Nutr. 2023 Jun;42(6):1036-1040. doi: 10.1016/j.clnu.2023.04.022. Epub 2023 Apr 27.
9
CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19.基于 CT 的胸部肌肉指标预测 COVID-19 患者的预后。
Radiology. 2021 Aug;300(2):E328-E336. doi: 10.1148/radiol.2021204141. Epub 2021 Mar 16.
10
Prognostic significance of low pectoralis muscle mass on preoperative chest computed tomography in localized non-small cell lung cancer after curative-intent surgery.局部非小细胞肺癌根治性手术后,术前胸部计算机断层扫描显示胸肌质量低的预后意义。
Lung Cancer. 2020 Sep;147:71-76. doi: 10.1016/j.lungcan.2020.07.008. Epub 2020 Jul 7.

引用本文的文献

1
CT scan-derived pectoralis muscle parameters are closely associated with COVID-19 outcomes: A systematic review and meta-analysis.CT扫描得出的胸肌参数与COVID-19的预后密切相关:一项系统评价和荟萃分析。
PLoS One. 2025 Jan 28;20(1):e0316893. doi: 10.1371/journal.pone.0316893. eCollection 2025.
2
Vertebral HU value and the pectoral muscle index based on chest CT can be used to opportunistically screen for osteoporosis.基于胸部 CT 的椎体 HU 值和胸肌指数可用于骨质疏松症的机会性筛查。
J Orthop Surg Res. 2024 Jun 7;19(1):335. doi: 10.1186/s13018-024-04825-6.
3
The identification of an optimal body size parameter to adjust skeletal muscle area on chest CT in COVID-19 patients.

本文引用的文献

1
Prognostic Role of the Pectoralis Musculature in Patients with COVID-19. A Multicenter Study.胸肌在 COVID-19 患者中的预后作用。一项多中心研究。
Acad Radiol. 2023 Jan;30(1):77-82. doi: 10.1016/j.acra.2022.05.003. Epub 2022 May 16.
2
Coronavirus disease 2019 (Covid-19) outcomes in patients with sarcopenia: A meta-analysis and meta-regression.新型冠状病毒病 2019(COVID-19)患者肌少症的结局:一项荟萃分析和荟萃回归。
Clin Nutr ESPEN. 2022 Apr;48:158-166. doi: 10.1016/j.clnesp.2022.01.016. Epub 2022 Jan 24.
3
Lower skeletal muscle mass on CT body composition analysis is associated with adverse clinical course and outcome in children with COVID-19.
确定用于调整COVID-19患者胸部CT上骨骼肌面积的最佳身体尺寸参数。
J Frailty Sarcopenia Falls. 2024 Mar 1;9(1):16-24. doi: 10.22540/JFSF-09-016. eCollection 2024 Mar.
4
Response to the Commentary on: "Pectoralis muscle area measured at T4 level is closely associated with adverse COVID-19 outcomes in hospitalized patients".对关于“在T4水平测量的胸肌面积与住院COVID-19患者的不良预后密切相关”的评论的回应
J Musculoskelet Neuronal Interact. 2024 Mar 1;24(1):102.
5
Commentary to: Pectoralis Muscle Area Measured at T4 Level is Closely Associated With Adverse COVID-19 Outcomes in Hospitalized Patients.对《T4水平测量的胸肌面积与住院COVID-19患者不良预后密切相关》的评论
J Musculoskelet Neuronal Interact. 2024 Mar 1;24(1):101.
CT 体成分分析显示骨骼肌质量较低与 COVID-19 患儿的不良临床病程和结局相关。
Radiol Med. 2022 Apr;127(4):440-448. doi: 10.1007/s11547-022-01462-z. Epub 2022 Feb 21.
4
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium.老年癌症患者发生严重 COVID-19 结局的老年病学风险因素:来自 COVID-19 和癌症联合会的队列研究。
Lancet Healthy Longev. 2022 Mar;3(3):e143-e152. doi: 10.1016/S2666-7568(22)00009-5. Epub 2022 Feb 14.
5
Disease burden and vaccination priorities in Colombia.哥伦比亚的疾病负担和疫苗接种重点。
Vaccine. 2022 Mar 15;40(12):1717-1721. doi: 10.1016/j.vaccine.2022.01.014. Epub 2022 Feb 15.
6
Thoracic sarcopenia as a predictive factor of SARS-COV2 evolution.胸肌减少症作为 SARS-CoV-2 演变的预测因素。
Clin Nutr. 2022 Dec;41(12):2918-2923. doi: 10.1016/j.clnu.2022.01.022. Epub 2022 Jan 30.
7
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis.三种新型口服抗病毒药物(莫努匹韦、氟伏沙明和帕罗韦德)治疗 COVID-19 的疗效和安全性:一项荟萃分析。
Ann Med. 2022 Dec;54(1):516-523. doi: 10.1080/07853890.2022.2034936.
8
COVID-19 CT Scan Lung Segmentation: How We Do It.COVID-19 CT 扫描肺部分割:我们的做法。
J Digit Imaging. 2022 Jun;35(3):424-431. doi: 10.1007/s10278-022-00593-z. Epub 2022 Jan 28.
9
Impact of sarcopenia in SARS-CoV-2 patients during two different epidemic waves.肌少症对两次不同流行波中 SARS-CoV-2 患者的影响。
Clin Nutr ESPEN. 2022 Feb;47:252-259. doi: 10.1016/j.clnesp.2021.12.001. Epub 2021 Dec 7.
10
Impact of pretransplant frailty and sarcopenia on the post-transplant prognosis of patients with liver cirrhosis: a systematic review.肝硬化患者移植前衰弱和肌少症对移植后预后的影响:系统评价。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e883-e897. doi: 10.1097/MEG.0000000000002291.